2022
Suh M , Movva N, Jiang X, Reichert H, Bylsma LC, Fryzek JP, Nelson CB. 2022. Respiratory syncytial virus burden and healthcare utilization in United States infants, <1 year of age: Study of nationally representative databases, 2011–2019. J Infect Dis 226(Suppl 2):S184–S194; doi: 10.1093/infdis/jiac155 . PMID: 35968879.
View Abstract
Topics: Epidemiology
Movva N, Suh M , Reichert H, Hitze B, Sendak MP, Wolf Z, et al. 2022. Respiratory syncytial virus during the COVID-19 pandemic compared to historic levels: A retrospective cohort study of a health system. J Infect Dis 226(Suppl 2):S175–S183; doi: 10.1093/infdis/jiac220 . PMID: 35968868.
View Abstract
Topics: COVID-19 , Epidemiology
Suh M , Movva N, Jiang X, Bylsma LC, Reichert H, Fryzek JP, Nelson CB. 2022. Respiratory syncytial virus (RSV) is the leading cause of United States infant hospitalizations 2009–2019: A study of the National (Nationwide) Inpatient Sample. J Infect Dis 226(Suppl 2):S154–S163; doi: 10.1093/infdis/jiac120 . PMID: 35968878.
View Abstract
Topics: Epidemiology
Goyak KO, Sarang SS, Franzen A , Borghoff SJ , Ryman-Rasmussen JP. 2022. Adverse outcome pathway (AOP): α2u-globulin nephropathy and kidney tumors in male rats. Crit Rev Toxicol, open access .
View Abstract
Topics: Toxicology
House JS, Grimm FA, Klaren WD , Dalzell A, Kuchi S, Zhang S, Lenz K, Boogaard PJ, Ketelsegers HB, Gant TW, Wright FA, Rusyn I. 2022. Grouping of UVCB substances with dose-response transcriptomics data from human cell-based assays. ALTEX 39(3):388-404; doi: 10.14573/altex.2107051 . PMID: 35288757.
View Abstract
Topics: Toxicology
Rankin DA, Haddadin Z, Lipworth L, Stahl AL, Fryzek J, Suh M , et al. 2022. Comparison of clinical presentations and burden of respiratory syncytial virus in infants across three distinct healthcare settings in Davidson County, Tennessee. Therapeut Adv Infect Dis 9(July 18):20499361221112171; doi: 10.1177/20499361221112171 . PMID: 35875809.
View Abstract
Topics: Epidemiology
Lea IA , Pham LL, Antonijevic T, Thompson C , Borghoff SJ . 2022. Assessment of the applicability of the threshold of toxicological concern for per- and polyfluoroalkyl substances. Regul Toxicol Pharmacol 133:105190, open access .
View Abstract
Topics: PFAS , Toxicology
Lea IA , Pham LL, Antonijevic T, Thompson C , Borghoff SJ . 2022. Assessment of the applicability of the threshold of toxicological concern for per- and polyfluoroalkyl substances. Regul Toxicol Pharmacol 133(August):105190; doi: 10.1016/j.yrtph.2022.105190 . PMID: 35662637.
View Abstract
Topics: PFAS , Toxicology
Hoffmann S, Aiassa E, Angrish M, Beausoleil C, Bois FY… Wikoff D , et al. 2022. Application of evidence-based methods to construct mechanism-driven chemical assessment frameworks. ALTEX 39(3):499-518; doi: 10.14573/altex.2202141 .
View Abstract
Topics: risk assessment , Toxicology
Chappell GA, Wolf JC, Thompson CM . 2021. Crypt and villus transcriptomic responses in mouse small intestine following oral exposure to hexavalent chromium. Toxicol Sci, kfab152, doi: 10.1093/toxsci/kfab152. Epub ahead of print . PMID: 34935971.
View Abstract